Description
Description
Flat-cylindrical tablets with a bevel and bevel, from white to almost white. MATERIA MEDICA is inscribed on the flat side with the risk, IMPAZA is inscribed on the other flat side.
Latin name
Impaza
Release form
lozenges. On 20 tablets in a blister strip packaging from a film of polyvinyl chloride and aluminum foil.
Each blister pack with medical instructions is placed in a cardboard box.
Pharmacological action
Pharmacotherapeutic group
Drugs for the treatment of erectile dysfunction.
ATX code
G04BE
Pharmacological action of
Increases the activity of endothelial NO synthase, restores the production of nitric oxide (NO) by endothelium during sexual stimulation, increases the content of cyclic guanosine monophosphate (cGMP) in smooth muscles and promotes their relaxation, which leads to an increase in blood supply to the cavernous bodies and provides an erection of sufficient strength and duration.
The drug increases libido (sex drive) and sexual satisfaction. Regular use of the drug helps increase serum testosterone levels (with a moderately reduced baseline).
Indications
Erectile dysfunction (erectile dysfunction) of various origins.
Vegetative disorders of menopause in men (weakness, fatigue, decreased physical activity, decreased libido, etc.).
Contraindications
Increased individual sensitivity to the components of the drug under the age of 18 years, lactase deficiency, lactose intolerance, glucose-galactose malabsorption.
Use during pregnancy and lactation
Impaza is not intended for use in women.
Composition
Composition (per 1 tablet)
Active components: Antibodies to endothelial NO synthase affinity purified – 0.003 g *.
Excipients: lactose monohydrate 0.267 g, microcrystalline cellulose 0.03 g, magnesium stearate 0.003 g.
* are applied to lactose monohydrate in the form of a water-alcohol mixture with a content of not more than 10-15 ng / g of the active form of the active substance.
Dosage and administration
At one time – 1 tablet (keep in mouth until completely dissolved – not during meals) .
Regular intake. To stabilize sexual potency (ability to have sexual intercourse), a treatment and prevention course lasting at least 12 weeks is recommended. Depending on the severity of erectile dysfunction, the frequency of administration can vary: from 1 tablet every other day to two doses per tablet daily, preferably in the evening.
If necessary, course therapy can be repeated after 3-6 months.
Intermittent use. For episodic stimulation of an erection, the drug is taken before intercourse, 2 tablets 1-2 hours before the alleged proximity.
Side effects
When using the drug for the indicated indications and at the indicated dosages, no side effects were detected.
Possible reactions of increased individual sensitivity to the components of the drug.
Medicinal interactions
Possible to use in combination therapy the use of Impase on the background of nitrates in patients with ischemic heart disease (angina pectoris I-II functional class), as well as the use of mixtures Together with beta-blockers, diuretics, angiotensin-converting enzyme (ACE) inhibitors, calcium antagonists.
Overdose
In case of accidental overdose, dyspepsia may occur due to excipients included in the dosage form.
Storage conditions
At a temperature not exceeding 25 ° C.
Keep out of the reach of children.
During the period of use of the drug, store blister packs in a cardboard box provided by the manufacturer.
Expiration
3 years.
Deystvuyuschee substances
Homeopatycheskyy composition
pharmacy leave conditions without a prescription
dosage form
dosage form
lozenges
Materia Medica Holding, Russia
